Increased apoptosis was induced by curcumin + silymarin combination treatment of DLD-1 colon cancer cells.
The combination of 2 plant compounds that have medicinal properties – curcumin and silymarin – holds promise in treating colon cancer, according Saint Louis University research published in the June 23 issue of the Journal of Cancer. Curcumin is the active ingredient in the spice turmeric, which is present in spicy curry dishes, and silymarin is a component of milk thistle, which has been used to treat liver disease.
The researchers and their students studied a line of colon cancer cells in a laboratory model. They found treating the cells initially with curcumin, then with silymarin was more effective in fighting cancer than treating the cells with either phytochemical alone.
“The co...
Read More
Recent Comments